BACKGROUND AND OBJECTIVE: Survival of patients with pancreatic adenocarcinoma is limited and few prognostic factors are known. We conducted a two-stage genome-wide association study (GWAS) to identify germline variants associated with survival in patients with pancreatic adenocarcinoma. METHODS: We analysed overall survival in relation to single nucleotide polymorphisms (SNPs) among 1005 patients from two large GWAS datasets, PanScan I and ChinaPC. Cox proportional hazards regression was used in an additive genetic model with adjustment for age, sex, clinical stage and the top four principal components of population stratification. The first stage included 642 cases of European ancestry (PanScan), from which the top SNPs (p≤10(-5)) were advanced to a joint analysis with 363 additional patients from China (ChinaPC). RESULTS: In the first stage of cases of European descent, the top-ranked loci were at chromosomes 11p15.4, 18p11.21 and 1p36.13, tagged by rs12362504 (p=1.63×10(-7)), rs981621 (p=1.65×10(-7)) and rs16861827 (p=3.75×10(-7)), respectively. 131 SNPs with p≤10(-5) were advanced to a joint analysis with cases from the ChinaPC study. In the joint analysis, the top-ranked SNP was rs10500715 (minor allele frequency, 0.37; p=1.72×10(-7)) on chromosome 11p15.4, which is intronic to the SET binding factor 2 (SBF2) gene. The HR (95% CI) for death was 0.74 (0.66 to 0.84) in PanScan I, 0.79 (0.65 to 0.97) in ChinaPC and 0.76 (0.68 to 0.84) in the joint analysis. CONCLUSIONS: Germline genetic variation in the SBF2 locus was associated with overall survival in patients with pancreatic adenocarcinoma of European and Asian ancestry. This association should be investigated in additional large patient cohorts.
BACKGROUND AND OBJECTIVE: Survival of patients with pancreatic adenocarcinoma is limited and few prognostic factors are known. We conducted a two-stage genome-wide association study (GWAS) to identify germline variants associated with survival in patients with pancreatic adenocarcinoma. METHODS: We analysed overall survival in relation to single nucleotide polymorphisms (SNPs) among 1005 patients from two large GWAS datasets, PanScan I and ChinaPC. Cox proportional hazards regression was used in an additive genetic model with adjustment for age, sex, clinical stage and the top four principal components of population stratification. The first stage included 642 cases of European ancestry (PanScan), from which the top SNPs (p≤10(-5)) were advanced to a joint analysis with 363 additional patients from China (ChinaPC). RESULTS: In the first stage of cases of European descent, the top-ranked loci were at chromosomes 11p15.4, 18p11.21 and 1p36.13, tagged by rs12362504 (p=1.63×10(-7)), rs981621 (p=1.65×10(-7)) and rs16861827 (p=3.75×10(-7)), respectively. 131 SNPs with p≤10(-5) were advanced to a joint analysis with cases from the ChinaPC study. In the joint analysis, the top-ranked SNP was rs10500715 (minor allele frequency, 0.37; p=1.72×10(-7)) on chromosome 11p15.4, which is intronic to the SET binding factor 2 (SBF2) gene. The HR (95% CI) for death was 0.74 (0.66 to 0.84) in PanScan I, 0.79 (0.65 to 0.97) in ChinaPC and 0.76 (0.68 to 0.84) in the joint analysis. CONCLUSIONS: Germline genetic variation in the SBF2 locus was associated with overall survival in patients with pancreatic adenocarcinoma of European and Asian ancestry. This association should be investigated in additional large patient cohorts.
Entities:
Keywords:
Cancer Genetics; Molecular Epidemiology; Pancreatic Cancer
Authors: Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani Journal: Cancer Cell Date: 2012-03-20 Impact factor: 31.743
Authors: Rachael Z Stolzenberg-Solomon; Barry I Graubard; Suresh Chari; Paul Limburg; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes Journal: JAMA Date: 2005-12-14 Impact factor: 56.272
Authors: Fergus J Couch; Xianshu Wang; William R Bamlet; Mariza de Andrade; Gloria M Petersen; Robert R McWilliams Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-01 Impact factor: 4.254
Authors: Kofi Asomaning; Amy E Reid; Wei Zhou; Rebecca S Heist; Rihong Zhai; Li Su; Eunice L Kwak; Lawrence Blaszkowsky; Andrew X Zhu; David P Ryan; David C Christiani; Geoffrey Liu Journal: Clin Cancer Res Date: 2008-06-15 Impact factor: 12.531
Authors: Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson Journal: Science Date: 2009-05-21 Impact factor: 47.728
Authors: Brian M Wolpin; Peter Kraft; Myron Gross; Kathy Helzlsouer; H Bas Bueno-de-Mesquita; Emily Steplowski; Rachael Z Stolzenberg-Solomon; Alan A Arslan; Eric J Jacobs; Andrea Lacroix; Gloria Petersen; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Garnet Anderson; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Stephen J Chanock; Sandra Clipp; John Michael Gaziano; Edward L Giovannucci; Göran Hallmans; Susan E Hankinson; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin Jacobs; Charles Kooperberg; Shannon M Lynch; Julie B Mendelsohn; Dominique S Michaud; Kim Overvad; Alpa V Patel; Aleksandar Rajkovic; Maria-José Sanchéz; Xiao-Ou Shu; Nadia Slimani; Gilles Thomas; Geoffrey S Tobias; Dimitrios Trichopoulos; Paolo Vineis; Jarmo Virtamo; Jean Wactawski-Wende; Kai Yu; Anne Zeleniuch-Jacquotte; Patricia Hartge; Charles S Fuchs Journal: Cancer Res Date: 2010-01-26 Impact factor: 12.701
Authors: Elizabeth M Azzato; Jonathan Tyrer; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Rüdiger Schulz-Wendtland; Stig E Bojesen; Børge G Nordestgaard; Henrik Flyger; Roger L Milne; José Ignacio Arias; Primitiva Menéndez; Javier Benítez; Jenny Chang-Claude; Rebecca Hein; Shan Wang-Gohrke; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jonathan Beesley; Xiaoqing Chen; Georgia Chenevix-Trench; Fergus J Couch; Janet E Olson; Zachary S Fredericksen; Xianshu Wang; Graham G Giles; Gianluca Severi; Laura Baglietto; Melissa C Southey; Peter Devilee; Rob A E M Tollenaar; Caroline Seynaeve; Montserrat García-Closas; Jolanta Lissowska; Mark E Sherman; Kelly L Bolton; Per Hall; Kamila Czene; Angela Cox; Ian W Brock; Graeme C Elliott; Malcolm W R Reed; David Greenberg; Hoda Anton-Culver; Argyrios Ziogas; Manjeet Humphreys; Douglas F Easton; Neil E Caporaso; Paul D P Pharoah Journal: J Natl Cancer Inst Date: 2010-03-22 Impact factor: 13.506
Authors: H Azzedine; A Bolino; T Taïeb; N Birouk; M Di Duca; A Bouhouche; S Benamou; A Mrabet; T Hammadouche; T Chkili; R Gouider; R Ravazzolo; A Brice; J Laporte; E LeGuern Journal: Am J Hum Genet Date: 2003-04-08 Impact factor: 11.025
Authors: Sahar Shahamatdar; Meng Xiao He; Matthew A Reyna; Alexander Gusev; Saud H AlDubayan; Eliezer M Van Allen; Sohini Ramachandran Journal: Cell Rep Date: 2020-03-03 Impact factor: 9.423
Authors: Roelof Koster; Orestis A Panagiotou; William A Wheeler; Eric Karlins; Julie M Gastier-Foster; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Adrienne M Flanagan; Roberto Tirabosco; Irene L Andrulis; Jay S Wunder; Nalan Gokgoz; Ana Patiño-Garcia; Fernando Lecanda; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; David M Thomas; Mandy L Ballinger; Richard Gorlick; Donald A Barkauskas; Logan G Spector; Margaret Tucker; D Hicks Belynda; Meredith Yeager; Robert N Hoover; Sholom Wacholder; Stephen J Chanock; Sharon A Savage; Lisa Mirabello Journal: Int J Cancer Date: 2017-12-23 Impact factor: 7.396
Authors: Melissa A Austin; Elena Kuo; Stephen K Van Den Eeden; Margaret T Mandelson; Teresa A Brentnall; Aruna Kamineni; John D Potter Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-21 Impact factor: 4.254